C07H15/248

ADJUVANT WITH TLR4 AGONIST ACTIVITY

The present invention relates to a compound useful as vaccine adjuvant, a manufacturing process thereof, a pharmaceutical composition comprising the compound, and use of the compound as vaccine adjuvant.